Why the study?
Do apoptosis inhibitors prevent neuronal loss in acute and chronic neurodegenerative conditions?
Population
Patients and animal models with acute and chronic neurodegenerative conditions
Design
Review
Authors
Loading...
Apoptosis inhibitors merit further preclinical and clinical testing in neurodegeneration; leaves open human efficacy and safety.
Do apoptosis inhibitors prevent neuronal loss in acute and chronic neurodegenerative conditions?
Apoptosis inhibitors, including caspase inhibitors and IAPs, show potential as therapeutic agents for preventing neuronal loss in acute and chronic neurodegenerative conditions.
Robertson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: